Qing Song HealthLtd Past Earnings Performance

Past criteria checks 3/6

Qing Song HealthLtd has been growing earnings at an average annual rate of 40.2%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 31.6% per year. Qing Song HealthLtd's return on equity is 7.3%, and it has net margins of 5.1%.

Key information

40.2%

Earnings growth rate

35.0%

EPS growth rate

Healthcare Industry Growth	9.1%
Revenue growth rate	31.6%
Return on equity	7.3%
Net Margin	5.1%
Last Earnings Update	30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Qing Song HealthLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TPEX:6931 Revenue, expenses and earnings (TWD Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
30 Sep 24	961	49	72	0
30 Jun 24	932	52	67	0
31 Mar 24	901	56	64	0
31 Dec 23	869	59	61	0
30 Sep 23	820	43	62	0
30 Jun 23	780	39	61	0
31 Mar 23	708	31	56	0
31 Dec 22	637	23	52	0
30 Sep 22	555	18	45	0
30 Jun 22	473	13	39	0
31 Mar 22	415	5	35	0
31 Dec 21	358	-2	32	0
31 Dec 20	240	16	23	3
31 Dec 19	124	13	15	9

Quality Earnings: 6931 has high quality earnings.

Growing Profit Margin: 6931's current net profit margins (5.1%) are lower than last year (5.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 6931's earnings have grown significantly by 40.2% per year over the past 5 years.

Accelerating Growth: 6931's earnings growth over the past year (14.4%) is below its 5-year average (40.2% per year).

Earnings vs Industry: 6931 earnings growth over the past year (14.4%) exceeded the Healthcare industry 7.3%.

Return on Equity

High ROE: 6931's Return on Equity (7.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/25 13:04
End of Day Share Price	2024/12/25 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Qing Song Health Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution